| __timestamp | BioMarin Pharmaceutical Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 129764000 | 4167274 |
| Thursday, January 1, 2015 | 152008000 | 5247851 |
| Friday, January 1, 2016 | 209620000 | 4925118 |
| Sunday, January 1, 2017 | 241786000 | 14930297 |
| Monday, January 1, 2018 | 315264000 | 25371768 |
| Tuesday, January 1, 2019 | 359466000 | 23921274 |
| Wednesday, January 1, 2020 | 524272000 | 25338236 |
| Friday, January 1, 2021 | 470515000 | 20182966 |
| Saturday, January 1, 2022 | 483669000 | 17562000 |
| Sunday, January 1, 2023 | 577065000 | 25212000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for BioMarin Pharmaceutical Inc. and Pharming Group N.V. from 2014 to 2023. Over this period, BioMarin's cost of revenue surged by approximately 345%, peaking in 2023. In contrast, Pharming Group N.V. experienced a more modest increase of around 505%, albeit from a much smaller base.
BioMarin's cost of revenue consistently outpaced Pharming's, reflecting its larger scale and broader market reach. However, Pharming's rapid growth in cost efficiency highlights its potential for scaling operations. This comparison underscores the diverse strategies employed by pharmaceutical companies to manage costs while striving for innovation and market expansion. As the industry continues to grow, understanding these dynamics is crucial for investors and stakeholders alike.
Cost of Revenue Comparison: AbbVie Inc. vs Pharming Group N.V.
Gilead Sciences, Inc. vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: BeiGene, Ltd. vs BioMarin Pharmaceutical Inc.
Cost Insights: Breaking Down Incyte Corporation and BioMarin Pharmaceutical Inc.'s Expenses
BioMarin Pharmaceutical Inc. or Pharming Group N.V.: Who Invests More in Innovation?
Cost of Revenue Trends: BioMarin Pharmaceutical Inc. vs ADMA Biologics, Inc.
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs PTC Therapeutics, Inc.
BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: BioMarin Pharmaceutical Inc. vs Wave Life Sciences Ltd.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Galapagos NV
BioMarin Pharmaceutical Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored